Such changes may constitute or at least contribute to the biological basis of the exacerbation of WD and suggest that in addition to M. tuberculosis and HBV, patients with unexplained arthropathy should be screened for T. whipplei infection prior to introduction of anti-TNF therapy. This evidence concerns the gene TNF and arthropathy.